Exosomal Biomarker Discovery

3D Bloom


Plug & play with standard liquid handling


Chemically defined microenvironment for 3D culture


Plug & play with standard liquid handling


Christopher Millan, PhD

CellSpring co-founder and inventor of 3D Bloom.  Dr. Millan leads fundraising and business development.

Queralt Vallmajó, PhD

An experienced scientist who recently completed her PhD at EPFL, Dr. Vallmajó now directs R&D efforts at CellSpring.

Daniel Eberli, MD/PhD

Urologist and principal investigator at the University Hospital in Zurich.  Prof. Eberli acts as scientific advisor to CellSpring and his lab collaborates with us to drive clinical proof of concept of our prostate cancer biomarkers.


Latest News


May 2019, Renens, Switzerland: CellSpring selected to participate in the MassChallenge accelerator program.  We were selected after two rounds of judging from a pool of over 1'000 applicants. 

Oct. 2018, Zurich, Switzerland: USZ lab of Prof. Daniel Eberli awarded a research grant for CellSpring collaboration. The focus of the project is discovery of novel biomarkers for prostate cancer.

Feb. 2017, London, U.K.: Forbes named co-founder Christopher Millan to its annual 30 Under 30 list for Europe.  Dr. Millan was named to two categories: Science & Healthcare and Dorm Room Founders

  • White LinkedIn Icon
  • White Facebook Icon
  • White Twitter Icon

© 2015 - 2020 CellSpring AG. All rights reserved.